ArticleCureus2024
Impact of Chorionicity in Neurodevelopmental Outcomes in Preterm Twins.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Multifetal pregnancies, which account for 2-4% of births worldwide, have increased in recent years. Twin pregnancies carry a higher risk of preterm birth and associated neonatal morbimortality, with monochorionic twins considered at greater risk. This study investigates the influence of chorionicity on neurodevelopmental outcomes in preterm twins. Methods A retrospective cohort study was conducted, including preterm twins born before 32 weeks of gestational age and/or with a birth weight of less than 1500 grams, admitted to a tertiary-hospital neonatal intensive care unit from 2013 to 2021. Neurodevelopmental outcomes were evaluated at 24 months of corrected age using the Griffiths II Mental Development Scales. Moderate to severe neurodevelopmental impairment was determined by the occurrence of one or more of the listed criteria: global development quotient <70, severe visual impairment, cerebral palsy, or profound sensorineural deafness. Results A total of 125 preterm twins were evaluated, of which 45% (n=56) were monochorionic. Overall, 5.6% (n=7) of the infants had moderate to severe neurodevelopmental impairment (NDI), with higher comorbidity rates in this group. No significant differences were found in NDI or other prematurity-related comorbidities between monochorionic and dichorionic twins. Gestational age over 27 weeks and birth weight over 1010 grams were identified as accurate predictors for an absence of moderate to severe NDI in these infants. Conclusion Chorionicity alone does not appear to independently affect neurodevelopmental outcomes in preterm twins when complications are effectively managed. Improved prenatal monitoring and appropriate treatment of twin pregnancies, especially monochorionic, are crucial to mitigate risks associated with moderate to severe neurodevelopmental impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.